Replies to post #2702 on Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

Just have a minor concern re 200,000 threshold for Cervical Cancer. This was the reason for rejection last time. Although they have not included CIN in this new application which should keep them below this figure.